Showing 21-30 of 34 grants

Title Institution Researcher Program Duration Total Award Amount
Development of targeted nanoparticles for delivering therapeutics to islet cells for treatment of T1D The Governing Council of the University of Toronto Xiao Yu (Shirley) Wu Cures 01-April-2023 to 31-March-2026 $899.710,00
Phase 2 clinical study evaluating ZT-01 for the prevention of nocturnal hypoglycemia in Type 1 diabetes Zucara Therapeutics Inc. Richard Liggins Improving Lives 01-June-2023 to 31-December-2025 $2.000.000,00
Using a virtual care platform to deliver peer-led mental health support to rural and remote communities in BC: A randomized wait-list controlled trial of the REACHOUT intervention The University of British Columbia Tricia Tang Improving Lives 01-September-2022 to 31-December-2025 $402.429,50
Safe and Immune Cloaked Stem Cell-Derived Beta-Cells: Treatment for Type 1 Diabetes Mellitus Sinai Health System Andras Nagy Cures 01-October-2022 to 30-September-2026 $1.124.391,15
Regenerating Human Pancreatic β Cells to Treat Diabetes Sunnybrook Research Institute Robert Screaton Cures 01-May-2022 to 31-May-2026 $900.000,00
Development of a trans-ancestral genetic risk score for type 1 diabetes Centre hospitalier universitaire Sainte-Justine Despoina Manousaki Cures 01-August-2022 to 31-July-2025 $597.800,00
Targeting Novel GPCRs to Promote Beta Cell Survival Sunnybrook Research Institute Robert Screaton Cures 01-February-2022 to 28-February-2026 $110.000,00
A pH responsive hydrogel microneedle patch for continuous measurement of ketone bodies and glucose University of Waterloo Mahla Poudineh Improving Lives 01-May-2022 to 30-April-2026 $1.180.795,50
A Novel, Dual-Hormone, Fully Automated Artificial Pancreas for Type 1 Diabetes McGill University Ahmad Haidar Improving Lives 01-October-2021 to 01-January-2026 $899.952,00
Vascular regenerative biomaterial (MAA) for islet transplantation The Governing Council of the University of Toronto Michael Sefton Cures 01-August-2021 to 30-November-2025 $506.807,41